** Shares of biopharmaceutical products maker Essex
Bio-Technology Ltd 1061.HK fall as much as 4.9% to HK$5.65,
after two consecutive sessions of gains
** Stock on track to mark its biggest intraday percentage
decline since Jan. 21
** Company says China's steps to curb spread of the
coronavirus have disrupted clinical operations of hospitals and
would interrupt sales process of its products, hitting its
turnover and results in the immediate months urn:newsml:reuters.com:*:nFWN2AH0F0
** As of the previous close, the stock had fallen 5.7% so
far this year
** Essex has underperformed the Hang Seng Commerce &
Industry Index sector .HSNC by 0.5 percentage points in the
past one month
** The Hang Seng China enterprises index .HSCE and the
benchmark index .HSI both fall 1.3%
(Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)